JTL Industries
NSE
₹ 0.00
0.00 (0.00)%
Small-cap
With a market cap of ₹18.90L Cr.
EX-Date | Purpose |
---|---|
27 04 2021 | Dividend & Audited Results Inter alia, to consider and approve: i. The Audited financial results (standalone) of the Company for the fourth quarter and year ended 31% March, 2021 ii. To consider & recommend the dividend for the financial year ended 31st March, 2021. iii. To consider all other matters incidental thereto and connected therewith. |
26 07 2021 | Quarterly Results |
07 08 2021 | Stock Split & Inter alia, to consider and approve a) Split of face value of equity shares and consequential alteration of the Memorandum and Articles of Association of the Company. b) Proposal to augment long-term resources of the Company including fund raising by issuance of securities and other matter(s) connected therewith and incidental thereto. |
12 10 2021 | Quarterly Results |
11 01 2022 | Inter alia, to consider: voluntarily delisting of Company s securities from Metropolitan Stock Exchange of India Limited (MSE) in compliance with the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2021. |
20 04 2022 | Audited Results |
05 05 2022 | Preferential Issue of shares Inter alia, to consider & approve issue and allot equity shares pursuant to exercise of option attached to convertible warrants issued on preferential basis in terms of SEBI (ICDR) Regulations, 2009 on March17, 2021, to Non-Promoters, Public Category entitling the warrant holders to get their warrants converted into equal number of equity shares within 18 months of warrant allotment |
22 07 2022 | Increase in Authorised Capital & Quarterly Results & Inter-alia to transact the following businesses: a. to consider & approve change in the name of the Company; b. to consider, evaluate and decide various options available for augmenting the long term funds/resources required for company?s business expansion plans and other matters incidental therewith and connected thereto; c. to increase in Authorised Share Capital of the Company and consequent amendments in Memorandum and Articles of Association of the Company; d. Any other item(s) with the permission of the Chair. |
13 09 2022 | Inter alia, to consider & approve issue and allot equity shares by conversion of warrants issued on preferential basis in terms of SEBI (ICDR) Regulations, 2018 on March 17, 2021 to Non Promoters, Public Category, entitling the warrant holders to get their warrants converted into equal number of equity shares within 18 months of warrant allotment, including benefits of corporate action, if any. |
10 10 2022 | Quarterly Results |
20 01 2023 | Preferential Issue of shares Inter alia, to consider & approve fund raising by way of preferential issue of securities and other allied matters |
02 02 2023 | Quarterly Results |
26 04 2023 | Final Dividend & Audited Results |
03 07 2023 | Inter-alia to consider to approve following: 1. To consider to approve Notice of Postal Ballot and other allied matters in connection with the appointment of Mr. Rakesh Mohan Garg as Additional Independent Director already appointed by the Board of Directors which is further subject to approval of the shareholders. 2. To consider fixation of Date of Annual General Meeting and matters. |
29 07 2023 | Bonus issue & Quarterly Results & Increase in Authorised Capital |
12 10 2023 | Quarterly Results |
18 12 2023 | Issue Of Warrants Inter alia, to consider raising of funds through issuance of equity shares or other securities convertible into Equity Shares including warrants or any combination thereof in one or more tranches, by way of Preferential Issue, Qualified Institutional Placement (?QIP?), Global Depository Receipts (?GDR?), American Depository Receipts (?ADR?) or through any other permissible mode or any combination thereof, in accordance with the applicable provisions of the Companies Act, 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, in such manner and on such terms and conditions as may be deemed appropriate by the Board in its absolute discretion, subject to approval from shareholders and receipt of any regulatory and statutory approvals, as applicable. Apart from this, the Board may discuss, approve or take note of any other matter as it may deem fit |
12 01 2024 | Quarterly Results |
03 10 2024 | Stock Split & Increase in Authorised Capital & Bonus issue |
30 10 2024 | Quarterly Results |
28 01 2025 | Voluntary Delisting of Shares & Quarterly Results |